Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SCH 497079 for weight loss in obese and overweight subjects
NCT00642993Phase 2Completed
- Sponsor
- Merck & Co.
- Start
- Jun 2008
- Primary completion
- Jan 2009
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of SCH 497079 in obesity, Overweight, sponsored by Merck & Co.. Started Jun 2008; status: completed.
02
Drugs
SCH 497079
03
Conditions
obesityOverweight
Beyond the preview
Go deeper on NCT00642993.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00642993.